Search by job, company or skills
Hospitals/Healthcare/Diagnostics
Department- DD&IT (Digital Data & IT) Product Supply
Are you passionate about managing IT systems Do you have a knack for ensuring smooth operations and compliance If so, we invite you to join us as a System Manager at Novo Nordisk. Read more and apply today for a life-changing career. Apply Now!
The position
As a System Manager for OMP you will be responsible for supervising the day-to-day usage, operation, and maintenance of the system and / or services. You will also:
Qualifications
We realise that few people are experts at everything. But if you can nod your head at the following attributes, then you could be the person we are looking for:
About the department
You will be joining the DD&IT Product Supply unit at Novo Nordisk. This unit is responsible for more than 40 global IT systems, including the operation, maintenance, support, and development of these systems. Our strategic objective is to be the IT partner for the business, providing the necessary solutions and support to meet the production and supply chain needs worldwide. The systems we manage, including SAP logistics modules like Sales and Distribution (SD), Materials Management (MM), and Advanced Planner Optimizer (APO), are critical to the execution of key business processes across the organisation. We work on a global scale, supporting all areas of the business, from R&D to Sales, and our systems are used 24x7 by thousands of Novo Nordisk users worldwide.
Working at Novo Nordisk
Novo Nordisk is a leading global healthcare company with a 100-year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63,000 employees around the world. We recognise the importance of the unique skills and perspectives our people bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk, we're working toward something bigger than ourselves, and it's a collective effort. Join us! Together, we go further. Together, we're life changing.
Contact
To submit your application, please upload your CV online (click on Apply and follow the instructions).
Deadline
2nd December 2024
Disclaimer
It has been brought to our attention that there have recently been instances of fraudulent job offers, purporting to be from Novo Nordisk and/or its affiliate companies. The individuals or organizations sending these false employment offers may pose as a Novo Nordisk recruiter or representative and request personal information, purchasing of equipment or funds to further the recruitment process or offer paid trainings. Be advised that Novo Nordisk does not extend unsolicited employment offers. Furthermore, Novo Nordisk does not charge prospective employees with fees or make requests for funding as a part of the recruitment process.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we're life changing.
Date Posted: 08/11/2024
Job ID: 99659985
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 5 countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (45%) of its voting shares.